TENAX THERAPEUTICS, INC. business relationships
Companies named in TENAX THERAPEUTICS, INC.’s 10-K filed 2026-03-10, and public companies whose annual reports name TENAX THERAPEUTICS, INC.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.6 / 10
- AI naming
- <1 / 100 Top 13% in its category
- Agent readiness
- 5 / 100
- AI adoption
- 0 / 100
Named in TENAX THERAPEUTICS, INC.’s annual report 1
“Through our agreement with our licensor, Orion Corporation, we have access to a library of ongoing and completed trials and research projects, including certain documentation, which we believe, in combination with positive Phase 3 data we hope to generate in at least one indication, will support FDA...” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.